Earlier, the Audit Committee of CMO had informed the SEC of the issues raised by the auditor from the audit of the company’s financial statements as follows: an irregular withdrawal of advance
Company Profile - JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์ Printed on 09 August 2024 20:12 Company Profile JSP
transaction is an appropriate and beneficial to the Company on a long- term basis, and no disagreement to the Company’s Board of Directors has been raised by the Company’s directors and/or the audit committee
disposition of Planet’s ordinary shares transaction is an appropriate and beneficial to the Company on a long-term basis, and no disagreement to the Company’s Board of Directors has been raised by the Company’s
from appreciation of Baht against other currencies causing lower revenue and gross profit although the company raised sales volume. For the year of 2018, the selling and administrative expenses was 27.86
currencies causing lower revenue and gross profit although the company raised sales volume. For the three-month period ended 31 March 2019, the selling and administrative expenses was 7.98 million Baht
sectors. Tourism was heavily affected by airspace and border closures, while merchandise exports fell sharply as demand from major trading partners fell, impacting both manufacturing production and domestic
or 22.90% over the same period of last year of which hospital revenues totally raised by 10.16% along with the enlarged customer base of Subsidiary (AMARC) showing 15.67% of revenues’ growth. In
internal audit report concerning cost of sales and inventories which were raised by the auditor. The said opinion must be submitted to the SEC within 5 working days from the date on which the audit committee